alexa The Research Progress And Biomarker Research Of Chronic Prostatitis
ISSN: 2161-1459

Journal of Clinical & Experimental Pharmacology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

8th World Congress on Pharmacology and Toxicology
July 24-25, 2017 Melbourne, Australia

Zu-Yue Sun, Li Zhou and Yu-ling Jia
Shanghai Institute of Planned Parenthood Research, China
Posters & Accepted Abstracts: Clin Exp Pharmacol
DOI: 10.4172/2161-1459-C1-020
Abstract
Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) is an important public health problem. CP/CPPS is a poorly understood entity characterized by pelvic or perineal pain, irritative voiding symptoms and sexual dysfunction, and from a clinical point of view, is truly lacking a cause that would allow a more rational-driven therapy. As a common genitourinary disease of adult male, diagnosis, treatments and prognostic monitoring of prostatitis have always been the focus of clinical attention, as a result of its setbacks, such as complex pathogenesis and clinical symptoms, lacking specificity in medication and its high rate of recurrence and so on. Currently, there isn’t a golden standard in diagnosis of prostatitis, while the detection of biomarkers can be helpful for the diagnosis, treatment and prognostic monitoring of prostatitis. Following significant improvements of the methods of detection in biological fluids, a number of prostate inflammation biomarkers were identified and quantified, in peripheral blood, urine and seminal plasma. In fact, White Blood Cells (WBC) count in Expressed Prostatic Secretions (EPS) has long been considered as the marker of prostatitis. However, it does not appear to be the optimal marker of inflammation and the current categorization of chronic prostatitis/chronic pelvic pain syndrome IIIB and asymptomatic inflammatory prostatitis as inflammatory or non-inflammatory based on WBC count appears to offer little clinically useful information and whilst WBC can be found in the prostatic fluid or seminal plasma of asymptomatic men as well as in that of men with pelvic pain. Also, the measures of the NIH-CP Symptom Index in symptomatic men show no correlation with WBC in EPS or seminal plasma. As the prostatitis biomarkers, cytokines/chemokine may have high sensitivity and good specificity. Cytokines are regulatory proteins released by various cellular subtypes that promote intercellular communication and immune responses. Chemokines are a subset of cytokines that recruit and activate immune cells to sites of inflammation. Interleukin 8 (IL-8) is a pro-inflammatory cytokine and plays an important role in different inflammatory diseases. Significant correlations between IL-8 levels and symptom score results were found. IL-8 values strongly correlated with CP/CPPS. Moreover, the patients with higher levels of IL-8 reported the worst symptoms. The study has shown that IL-8 was significantly elevated compared to controls in patients with CP/CPPS IIIA, CP/CPPS IIIB and benign prostatic hyperplasia (BPH). IL-8 is a reliable biomarker in seminal plasma for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) and for BPH and also the IL-8 levels were correlated with symptom scores and serum PSA values, increasing its value as a biomarker for prostate inflammation. Monocyte Chemoattractant Protein-1 (MCP-1) and macrophage inflammatory protein-1α (MIP-1α) recruit monocytes and macrophages via their release from fibroblasts and macrophages in joints of patients with rheumatoid arthritis and perpetuate the inflammatory process. For MCP-1 and MIP-1α, chronic pelvic pain syndrome subtypes had statistically higher levels than the control group and patients with benign prostatic hyperplasia. MCP-1 and MIP-1α within the prostatic fluid in both chronic pelvic pain syndrome subtypes provide candidate future biomarkers for chronic pelvic pain syndrome. In addition, macrophage inflammatory protein-1α increase in expressed prostatic secretions provides a new marker for clinical pain in chronic pelvic pain syndrome patients. Given these findings prostatic dysfunction likely has a role in the pathophysiology of this syndrome.
Biography

Zu-Yue Sun is the Research Director of National Evaluation Centre for the Toxicology of Fertility Regulating Drug. He has published more than 312 theses in China and abroad reputed journals.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords